157 reports of this reaction
1.5% of all AMANTADINE HYDROCHLORIDE reports
#17 most reported adverse reaction
CONFUSIONAL STATE is the #17 most commonly reported adverse reaction for AMANTADINE HYDROCHLORIDE, manufactured by Bionpharma Inc.. There are 157 FDA adverse event reports linking AMANTADINE HYDROCHLORIDE to CONFUSIONAL STATE. This represents approximately 1.5% of all 10,217 adverse event reports for this drug.
Patients taking AMANTADINE HYDROCHLORIDE who experience confusional state should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CONFUSIONAL STATE is a less commonly reported adverse event for AMANTADINE HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to confusional state, the following adverse reactions have been reported for AMANTADINE HYDROCHLORIDE:
The following drugs have also been linked to confusional state in FDA adverse event reports:
CONFUSIONAL STATE has been reported as an adverse event in 157 FDA reports for AMANTADINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
CONFUSIONAL STATE accounts for approximately 1.5% of all adverse event reports for AMANTADINE HYDROCHLORIDE, making it a notable side effect.
If you experience confusional state while taking AMANTADINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.